| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.972 | 0.002 | 0.972 | Topoisomerase II inhibitor | 0.967 0.002 DBMET00846 0.909 0.002 DBMET03627 0.944 0.002 DBMET01078 0.915 0.002 DBMET00647 0.615 0.004 DBMET00847 0.653 0.004 DBMET03628 0.579 0.005 DBMET03629 0.622 0.004 DBMET03630 | ||
| 0.968 | 0.001 | 0.968 | Topoisomerase II alpha inhibitor | 0.957 0.001 DBMET00846 0.873 0.002 DBMET03627 0.924 0.001 DBMET01078 0.872 0.002 DBMET00647 0.511 0.004 DBMET00847 0.566 0.004 DBMET03628 0.395 0.005 DBMET03629 0.502 0.004 DBMET03630 | ||
| 0.962 | 0.002 | 0.962 | DNA intercalator | 0.954 0.002 DBMET00846 0.861 0.002 DBMET03627 0.926 0.002 DBMET01078 0.857 0.002 DBMET00647 0.498 0.005 DBMET00847 0.553 0.005 DBMET03628 0.493 0.005 DBMET03629 0.477 0.005 DBMET03630 | ||
| 0.961 | 0.001 | 0.961 | DNA repair enzyme inhibitor | 0.913 0.001 DBMET00846 0.465 0.003 DBMET03627 0.545 0.002 DBMET01078 0.768 0.001 DBMET00647 0.198 0.009 DBMET00847 0.191 0.01 DBMET03628 0.148 0.033 DBMET03629 0.383 0.003 DBMET03630 | ||
| 0.947 | 0.002 | 0.947 | DNA damaging | 0.894 0.002 DBMET00846 0.713 0.005 DBMET03627 0.774 0.004 DBMET01078 0.828 0.003 DBMET00647 0.383 0.032 DBMET00847 0.382 0.032 DBMET03628 0.196 0.119 DBMET03629 0.386 0.032 DBMET03630 | ||
| 0.925 | 0.001 | 0.925 | Alkylator | 0.872 0.001 DBMET00846 0.561 0.004 DBMET03627 0.702 0.003 DBMET01078 0.89 0.001 DBMET00647 0.474 0.005 DBMET00847 0.501 0.005 DBMET03628 0.499 0.005 DBMET03629 0.637 0.003 DBMET03630 | ||
| 0.921 | 0 | 0.921 | Antibiotic Anthracycline-like | 0.726 0 DBMET00846 0.112 0.001 DBMET03627 0.244 0 DBMET01078 0.896 0 DBMET00647 0.112 0.001 DBMET00847 0.096 0.001 DBMET03628 0.048 0.002 DBMET03629 0.157 0 DBMET03630 | ||
| 0.907 | 0.002 | 0.907 | DNA synthesis inhibitor | 0.851 0.003 DBMET00846 0.492 0.014 DBMET03627 0.563 0.009 DBMET01078 0.841 0.003 DBMET00647 0.406 0.021 DBMET00847 0.475 0.015 DBMET03628 0.344 0.032 DBMET03629 0.591 0.008 DBMET03630 | ||
| 0.871 | 0.001 | 0.871 | Antineoplastic antibiotic | 0.869 0.001 DBMET00846 0.675 0.003 DBMET03627 0.777 0.002 DBMET01078 0.831 0.002 DBMET00647 0.606 0.003 DBMET00847 0.672 0.003 DBMET03628 0.578 0.003 DBMET03629 0.631 0.003 DBMET03630 | ||
| 0.872 | 0.008 | 0.872 | Transcription factor NF kappa B inhibitor | 0.79 0.013 DBMET00846 0.698 0.021 DBMET03627 0.788 0.014 DBMET01078 0.737 0.017 DBMET00647 0.538 0.039 DBMET00847 0.53 0.04 DBMET03628 0.36 0.074 DBMET03629 0.792 0.013 DBMET03630 | ||
| 0.856 | 0.001 | 0.856 | Expectorant | 0.791 0.002 DBMET00846 0.354 0.006 DBMET03627 0.477 0.004 DBMET01078 0.657 0.002 DBMET00647 0.223 0.016 DBMET00847 0.193 0.022 DBMET03628 0.095 0.075 DBMET03629 0.501 0.004 DBMET03630 | ||
| 0.841 | 0.003 | 0.848 | Antibacterial | 0.826 0.003 DBMET00846 0.535 0.032 DBMET03627 0.624 0.016 DBMET01078 0.848 0.003 DBMET00647 0.568 0.025 DBMET00847 0.603 0.019 DBMET03628 0.686 0.01 DBMET03629 0.774 0.005 DBMET03630 | DBMET00647 | |
| 0.786 | 0.001 | 0.786 | Mucolytic | 0.753 0.001 DBMET00846 0.31 0.004 DBMET03627 0.392 0.003 DBMET01078 0.572 0.002 DBMET00647 0.204 0.013 DBMET00847 0.189 0.016 DBMET03628 0.111 0.064 DBMET03629 0.186 0.017 DBMET03630 | ||
| 0.787 | 0.003 | 0.787 | Hypoxia-inducible factor 1 alpha inhibitor | 0.707 0.004 DBMET00846 0.732 0.004 DBMET03627 0.722 0.004 DBMET01078 0.648 0.005 DBMET00647 0.546 0.011 DBMET00847 0.506 0.014 DBMET03628 0.274 0.08 DBMET03629 0.511 0.014 DBMET03630 | ||
| 0.796 | 0.017 | 0.796 | Apoptosis agonist | 0.793 0.017 DBMET00846 0.744 0.024 DBMET03627 0.786 0.018 DBMET01078 0.693 0.032 DBMET00647 0.546 0.061 DBMET00847 0.566 0.057 DBMET03628 0.449 0.092 DBMET03629 0.666 0.036 DBMET03630 | ||
| 0.602 | 0.004 | 0.602 | DNA methylase inhibitor | 0.481 0.006 DBMET00846 0.377 0.013 DBMET03627 0.461 0.007 DBMET01078 0.289 0.031 DBMET00647 0.225 0.063 DBMET03630 | ||
| 0.594 | 0.001 | 0.594 | Topoisomerase II beta inhibitor | 0.507 0.001 DBMET00846 0.224 0.004 DBMET03627 0.262 0.003 DBMET01078 0.399 0.002 DBMET00647 0.084 0.012 DBMET00847 0.114 0.008 DBMET03628 0.084 0.012 DBMET03630 | ||
| 0.628 | 0.046 | 0.724 | Antiinflammatory | 0.602 0.053 DBMET00846 0.724 0.027 DBMET03627 0.691 0.033 DBMET01078 0.274 0.241 DBMET03629 0.649 0.041 DBMET03630 | DBMET03627 | |
| 0.548 | 0.006 | 0.625 | P-glycoprotein inhibitor | 0.517 0.007 DBMET00846 0.539 0.006 DBMET03627 0.625 0.005 DBMET01078 0.375 0.019 DBMET00647 0.264 0.037 DBMET00847 0.238 0.045 DBMET03628 0.211 0.057 DBMET03630 | DBMET01078 | |
| 0.534 | 0.004 | 0.534 | Protein kinase stimulant | 0.451 0.005 DBMET00846 0.333 0.013 DBMET03627 0.463 0.005 DBMET01078 0.464 0.005 DBMET00647 0.255 0.025 DBMET00847 0.227 0.033 DBMET03628 0.387 0.009 DBMET03630 | ||
| 0.534 | 0.004 | 0.534 | Topoisomerase I inhibitor | 0.507 0.004 DBMET00846 0.473 0.004 DBMET03627 0.506 0.004 DBMET01078 0.459 0.004 DBMET00647 0.315 0.01 DBMET00847 0.353 0.007 DBMET03628 0.302 0.011 DBMET03629 0.391 0.005 DBMET03630 | ||
| 0.531 | 0.016 | 0.669 | Caspase 3 stimulant | 0.466 0.026 DBMET00846 0.564 0.013 DBMET03627 0.669 0.007 DBMET01078 0.403 0.044 DBMET00647 0.345 0.061 DBMET00847 0.305 0.076 DBMET03628 0.325 0.068 DBMET03630 | DBMET01078 | |
| 0.508 | 0.003 | 0.525 | Cyclooxygenase 3 inhibitor | 0.432 0.004 DBMET00846 0.24 0.01 DBMET03627 0.348 0.005 DBMET01078 0.429 0.004 DBMET00647 0.215 0.014 DBMET00847 0.217 0.014 DBMET03628 0.525 0.003 DBMET03630 | DBMET03630 | |
| 0.525 | 0.027 | 0.552 | Immunosuppressant | 0.507 0.031 DBMET00846 0.518 0.028 DBMET03627 0.523 0.027 DBMET01078 0.487 0.036 DBMET00647 0.458 0.045 DBMET00847 0.49 0.036 DBMET03628 0.439 0.05 DBMET03629 0.552 0.02 DBMET03630 | DBMET03630 | |
| 0.405 | 0 | 0.405 | Ca2+-transporting ATPase inhibitor | 0.359 0 DBMET00846 0.253 0.001 DBMET03627 0.29 0.001 DBMET01078 0.329 0 DBMET00647 0.211 0.003 DBMET00847 0.214 0.003 DBMET03628 0.166 0.017 DBMET03629 0.204 0.003 DBMET03630 | ||
| 0.42 | 0.015 | 0.42 | Transcription factor STAT inhibitor | 0.218 0.114 DBMET00846 0.24 0.094 DBMET03627 0.363 0.029 DBMET01078 0.317 0.047 DBMET00647 0.184 0.162 DBMET03628 | ||
| 0.372 | 0.009 | 0.413 | Peptidyltransferase inhibitor | 0.359 0.011 DBMET00846 0.226 0.07 DBMET03627 0.253 0.048 DBMET01078 0.391 0.008 DBMET00647 0.285 0.031 DBMET00847 0.319 0.019 DBMET03628 0.244 0.055 DBMET03629 0.413 0.006 DBMET03630 | DBMET03630 | |
| 0.404 | 0.048 | 0.717 | Antithrombotic | 0.328 0.073 DBMET00846 0.212 0.163 DBMET03627 0.243 0.132 DBMET01078 0.519 0.027 DBMET00647 0.307 0.083 DBMET00847 0.336 0.069 DBMET03628 0.522 0.026 DBMET03629 0.717 0.007 DBMET03630 | DBMET03630 | |
| 0.339 | 0.049 | 0.668 | Antioxidant | 0.3 0.062 DBMET00846 0.349 0.047 DBMET03627 0.4 0.035 DBMET01078 0.387 0.037 DBMET00647 0.428 0.03 DBMET00847 0.48 0.022 DBMET03628 0.517 0.018 DBMET03629 0.668 0.007 DBMET03630 | DBMET03630 | |
| 0.316 | 0.029 | 0.371 | RNA-directed DNA polymerase inhibitor | 0.214 0.08 DBMET00846 0.27 0.04 DBMET03627 0.259 0.045 DBMET01078 0.263 0.043 DBMET00647 0.244 0.053 DBMET00847 0.275 0.038 DBMET03628 0.371 0.021 DBMET03629 0.208 0.088 DBMET03630 | DBMET03629 | |
| 0.285 | 0.024 | 0.562 | Melanin inhibitor | 0.206 0.038 DBMET00846 0.372 0.014 DBMET03627 0.354 0.016 DBMET01078 0.307 0.021 DBMET00647 0.41 0.011 DBMET00847 0.363 0.015 DBMET03628 0.131 0.112 DBMET03629 0.562 0.005 DBMET03630 | DBMET03630 | |
| 0.329 | 0.071 | 0.49 | Immunostimulant | 0.244 0.099 DBMET00846 0.167 0.141 DBMET03627 0.314 0.075 DBMET00647 0.168 0.141 DBMET00847 0.228 0.105 DBMET03628 0.331 0.07 DBMET03629 0.49 0.03 DBMET03630 | DBMET03630 | |
| 0.276 | 0.018 | 0.298 | Interleukin 6 antagonist | 0.298 0.015 DBMET00846 0.229 0.028 DBMET03627 0.192 0.046 DBMET01078 0.185 0.051 DBMET00647 0.189 0.048 DBMET03630 | DBMET00846 | |
| 0.261 | 0.004 | 0.261 | Transcription factor STAT6 inhibitor | 0.183 0.009 DBMET00846 0.121 0.057 DBMET03627 0.141 0.031 DBMET01078 0.21 0.006 DBMET00647 0.103 0.098 DBMET00847 0.138 0.034 DBMET03628 | ||
| 0.245 | 0.007 | 0.281 | HIV-1 integrase (Strand Transfer) inhibitor | 0.19 0.01 DBMET00846 0.25 0.006 DBMET03627 0.281 0.005 DBMET01078 0.116 0.018 DBMET00647 0.082 0.03 DBMET00847 0.104 0.021 DBMET03628 0.272 0.005 DBMET03629 0.076 0.033 DBMET03630 | DBMET01078 | |
| 0.292 | 0.054 | 0.471 | Antiamyloidogenic | 0.445 0.022 DBMET03627 0.471 0.019 DBMET01078 0.157 0.138 DBMET00647 0.28 0.059 DBMET00847 0.229 0.081 DBMET03628 0.316 0.047 DBMET03630 | DBMET01078 | |
| 0.26 | 0.025 | 0.402 | Amylase inhibitor | 0.229 0.035 DBMET00846 0.197 0.045 DBMET03627 0.188 0.049 DBMET01078 0.242 0.03 DBMET00647 0.192 0.047 DBMET00847 0.215 0.039 DBMET03628 0.402 0.009 DBMET03630 | DBMET03630 | |
| 0.285 | 0.055 | 0.593 | Angiogenesis stimulant | 0.278 0.058 DBMET00846 0.145 0.126 DBMET03627 0.156 0.119 DBMET01078 0.274 0.059 DBMET00647 0.166 0.113 DBMET03628 0.387 0.024 DBMET03629 0.593 0.007 DBMET03630 | DBMET03630 | |
| 0.307 | 0.081 | 0.425 | Apoptosis antagonist | 0.287 0.094 DBMET00846 0.241 0.137 DBMET03627 0.305 0.082 DBMET01078 0.314 0.077 DBMET00647 0.258 0.12 DBMET00847 0.273 0.106 DBMET03628 0.425 0.032 DBMET03630 | DBMET03630 | |
| 0.228 | 0.008 | 0.271 | HIV-1 integrase (3'-Processing) inhibitor | 0.167 0.012 DBMET00846 0.236 0.007 DBMET03627 0.271 0.005 DBMET01078 0.122 0.019 DBMET00647 0.088 0.03 DBMET00847 0.113 0.021 DBMET03628 0.258 0.006 DBMET03629 0.08 0.034 DBMET03630 | DBMET01078 | |
| 0.265 | 0.048 | 0.422 | Nitric oxide antagonist | 0.243 0.053 DBMET00846 0.27 0.047 DBMET03627 0.305 0.039 DBMET01078 0.238 0.055 DBMET00647 0.234 0.056 DBMET00847 0.244 0.053 DBMET03628 0.183 0.075 DBMET03629 0.422 0.023 DBMET03630 | DBMET03630 | |
| 0.219 | 0.007 | 0.223 | Multidrug resistance-associated protein 1 inhibitor | 0.208 0.009 DBMET00846 0.199 0.01 DBMET03627 0.223 0.006 DBMET01078 0.162 0.02 DBMET00647 0.094 0.089 DBMET00847 0.209 0.009 DBMET03629 0.113 0.057 DBMET03630 | DBMET01078 | |
| 0.249 | 0.043 | 0.459 | Hepatoprotectant | 0.233 0.049 DBMET00846 0.228 0.051 DBMET03627 0.273 0.037 DBMET01078 0.248 0.044 DBMET00647 0.232 0.049 DBMET00847 0.258 0.041 DBMET03628 0.272 0.038 DBMET03629 0.459 0.009 DBMET03630 | DBMET03630 | |
| 0.235 | 0.031 | 0.364 | Interferon gamma antagonist | 0.178 0.051 DBMET00846 0.322 0.017 DBMET03627 0.284 0.022 DBMET01078 0.152 0.075 DBMET00647 0.213 0.036 DBMET00847 0.237 0.031 DBMET03628 0.364 0.013 DBMET03630 | DBMET03630 | |
| 0.221 | 0.018 | 0.23 | Interleukin 4 antagonist | 0.207 0.02 DBMET00846 0.23 0.016 DBMET03627 0.211 0.02 DBMET01078 0.158 0.043 DBMET00647 0.137 0.063 DBMET00847 0.155 0.045 DBMET03628 0.141 0.059 DBMET03630 | DBMET03627 | |
| 0.286 | 0.09 | 0.344 | Immunomodulator | 0.3 0.082 DBMET00846 0.238 0.125 DBMET00647 0.344 0.062 DBMET03630 | DBMET03630 | |
| 0.194 | 0.005 | 0.209 | Thioredoxin reductase inhibitor | 0.172 0.006 DBMET00846 0.194 0.005 DBMET03627 0.209 0.004 DBMET01078 0.146 0.01 DBMET00647 0.116 0.019 DBMET00847 0.117 0.018 DBMET03628 0.079 0.065 DBMET03629 0.083 0.055 DBMET03630 | DBMET01078 | |
| 0.251 | 0.069 | 0.348 | Vasodilator | 0.218 0.091 DBMET00846 0.279 0.056 DBMET03627 0.285 0.054 DBMET01078 0.235 0.078 DBMET00647 0.26 0.064 DBMET00847 0.247 0.07 DBMET03628 0.162 0.14 DBMET03629 0.348 0.034 DBMET03630 | DBMET03630 | |
| 0.242 | 0.072 | 0.527 | Free radical scavenger | 0.192 0.105 DBMET00846 0.223 0.081 DBMET03627 0.259 0.065 DBMET01078 0.265 0.063 DBMET00647 0.258 0.065 DBMET00847 0.294 0.053 DBMET03628 0.207 0.092 DBMET03629 0.527 0.014 DBMET03630 | DBMET03630 | |
| 0.179 | 0.014 | 0.323 | Selectin antagonist | 0.193 0.012 DBMET00846 0.198 0.011 DBMET00647 0.159 0.016 DBMET03629 0.323 0.005 DBMET03630 | DBMET03630 | |
| 0.158 | 0.006 | 0.159 | Protein 50S ribosomal subunit inhibitor | 0.152 0.006 DBMET00846 0.055 0.035 DBMET01078 0.159 0.006 DBMET00647 0.101 0.013 DBMET03630 | DBMET00647 | |
| 0.181 | 0.049 | 0.231 | NOS3 expression enhancer | 0.167 0.058 DBMET00846 0.195 0.043 DBMET03627 0.227 0.032 DBMET01078 0.231 0.031 DBMET03630 | DBMET03630 | |
| 0.308 | 0.185 | 0.599 | Caspase 9 stimulant | 0.599 0.036 DBMET03627 0.544 0.046 DBMET01078 0.297 0.198 DBMET00647 0.59 0.037 DBMET00847 0.548 0.045 DBMET03628 0.504 0.058 DBMET03630 | DBMET03627 | |
| 0.154 | 0.036 | 0.192 | Microtubule formation inhibitor | 0.164 0.031 DBMET00846 0.112 0.071 DBMET03627 0.139 0.044 DBMET01078 0.192 0.022 DBMET00647 0.148 0.039 DBMET00847 0.132 0.049 DBMET03628 0.16 0.033 DBMET03630 | DBMET00647 | |
| 0.104 | 0.003 | 0.107 | Antibiotic Aminoglycoside-like | 0.104 0.003 DBMET00846 0.034 0.029 DBMET01078 0.107 0.003 DBMET00647 0.035 0.027 DBMET00847 0.038 0.023 DBMET03628 0.076 0.005 DBMET03630 | DBMET00647 | |
| 0.103 | 0.002 | 0.103 | Ceramide glucosyltransferase inhibitor | 0.099 0.002 DBMET00846 0.044 0.012 DBMET03627 0.063 0.004 DBMET01078 0.067 0.004 DBMET00647 0.036 0.023 DBMET03628 0.036 0.025 DBMET03629 | ||
| 0.123 | 0.022 | 0.158 | Interleukin 5 antagonist | 0.102 0.039 DBMET00846 0.158 0.009 DBMET03627 0.136 0.015 DBMET01078 0.087 0.059 DBMET00647 0.106 0.035 DBMET00847 0.095 0.047 DBMET03628 0.095 0.048 DBMET03630 | DBMET03627 | |
| 0.101 | 0.003 | 0.102 | Protein 30S ribosomal subunit inhibitor | 0.087 0.004 DBMET00846 0.027 0.014 DBMET03627 0.029 0.013 DBMET01078 0.102 0.003 DBMET00647 0.031 0.012 DBMET00847 0.053 0.007 DBMET03628 0.022 0.019 DBMET03629 0.079 0.004 DBMET03630 | DBMET00647 | |
| 0.095 | 0.007 | 0.125 | Lipocortins synthesis agonist | 0.095 0.007 DBMET00846 0.125 0.003 DBMET03627 0.115 0.003 DBMET01078 0.054 0.05 DBMET00647 0.072 0.019 DBMET00847 0.076 0.016 DBMET03628 0.07 0.022 DBMET03629 0.081 0.013 DBMET03630 | DBMET03627 | |
| 0.15 | 0.068 | 0.401 | Lipid peroxidase inhibitor | 0.115 0.099 DBMET00846 0.239 0.029 DBMET03627 0.214 0.036 DBMET01078 0.179 0.051 DBMET00647 0.287 0.021 DBMET00847 0.329 0.015 DBMET03628 0.281 0.022 DBMET03629 0.401 0.009 DBMET03630 | DBMET03630 | |
| 0.132 | 0.056 | 0.132 | Beta amyloid protein antagonist | 0.122 0.065 DBMET00846 | ||
| 0.107 | 0.031 | 0.112 | ATPase (Vacuolar H+) inhibitor | 0.105 0.034 DBMET00846 0.085 0.066 DBMET01078 0.11 0.028 DBMET00647 0.082 0.075 DBMET00847 0.112 0.026 DBMET03630 | DBMET03630 | |
| 0.089 | 0.015 | 0.091 | Nitric oxide donor | 0.087 0.016 DBMET00846 0.091 0.014 DBMET03627 0.09 0.014 DBMET01078 0.065 0.041 DBMET03630 | DBMET03627 | |
| 0.12 | 0.055 | 0.184 | Estrogen antagonist | 0.112 0.07 DBMET00846 0.184 0.015 DBMET03627 0.157 0.021 DBMET01078 0.131 0.037 DBMET00847 0.152 0.023 DBMET03628 0.124 0.048 DBMET03629 0.111 0.072 DBMET03630 | DBMET03627 | |
| 0.22 | 0.157 | 0.382 | Interleukin 2 agonist | 0.223 0.152 DBMET00846 0.257 0.111 DBMET00647 0.214 0.166 DBMET03628 0.382 0.033 DBMET03630 | DBMET03630 | |
| 0.06 | 0.005 | 0.077 | Motilin receptor agonist | 0.077 0.005 DBMET00846 0.059 0.005 DBMET00647 | DBMET00846 | |
| 0.09 | 0.037 | 0.092 | T cell inhibitor | 0.078 0.073 DBMET00846 0.092 0.035 DBMET03627 0.08 0.065 DBMET01078 0.086 0.046 DBMET03630 | DBMET03627 | |
| 0.101 | 0.055 | 0.101 | DNA directed RNA polymerase inhibitor | 0.095 0.063 DBMET00846 | ||
| 0.088 | 0.043 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 DBMET00846 0.095 0.037 DBMET00647 0.076 0.055 DBMET00847 0.094 0.037 DBMET03628 0.104 0.028 DBMET03629 0.117 0.018 DBMET03630 | DBMET03630 | |
| 0.175 | 0.14 | 0.582 | Hypoglycemic | 0.164 0.157 DBMET00846 0.222 0.094 DBMET00647 0.205 0.107 DBMET00847 0.237 0.085 DBMET03628 0.582 0.009 DBMET03630 | DBMET03630 | |
| 0.066 | 0.034 | 0.108 | Androgen agonist | 0.062 0.038 DBMET00846 0.106 0.013 DBMET03627 0.1 0.015 DBMET01078 0.088 0.02 DBMET00847 0.108 0.012 DBMET03628 0.102 0.014 DBMET03629 | DBMET03628 | |
| 0.142 | 0.117 | 0.334 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET00846 0.332 0.016 DBMET03627 0.218 0.046 DBMET01078 0.311 0.019 DBMET00847 0.334 0.015 DBMET03628 0.249 0.034 DBMET03629 0.269 0.028 DBMET03630 | DBMET03628 | |
| 0.071 | 0.046 | 0.119 | HIV-1 integrase inhibitor | 0.116 0.017 DBMET03627 0.114 0.018 DBMET01078 0.076 0.041 DBMET00847 0.09 0.031 DBMET03628 0.119 0.016 DBMET03629 | DBMET03629 | |
| 0.031 | 0.006 | 0.057 | Corticosteroid-like | 0.031 0.006 DBMET00846 0.057 0.003 DBMET03627 0.045 0.004 DBMET01078 0.02 0.017 DBMET00847 0.022 0.013 DBMET03628 0.025 0.01 DBMET03630 | DBMET03627 | |
| 0.043 | 0.018 | 0.062 | Glucose-6-phosphate dehydrogenase inhibitor | 0.042 0.019 DBMET00846 0.062 0.006 DBMET03627 0.059 0.008 DBMET01078 | DBMET03627 | |
| 0.1 | 0.077 | 0.256 | Cystathionine beta-synthase inhibitor | 0.256 0.014 DBMET03627 0.215 0.021 DBMET01078 0.201 0.024 DBMET00847 0.22 0.02 DBMET03628 0.155 0.038 DBMET03630 | DBMET03627 | |
| 0.14 | 0.12 | 0.242 | ATPase inhibitor | 0.15 0.101 DBMET00647 0.242 0.015 DBMET03630 | DBMET03630 | |
| 0.023 | 0.006 | 0.023 | Antibiotic Macrolide-like | 0.023 0.006 DBMET00846 0.023 0.006 DBMET00647 | ||
| 0.082 | 0.065 | 0.134 | Transcription factor NF kappa B stimulant | 0.083 0.063 DBMET00846 0.098 0.04 DBMET00647 0.134 0.02 DBMET03630 | DBMET03630 | |
| 0.02 | 0.004 | 0.023 | Antibiotic Tetracycline-like | 0.015 0.014 DBMET00846 0.02 0.004 DBMET03627 0.02 0.004 DBMET01078 0.019 0.004 DBMET00647 0.02 0.004 DBMET00847 0.023 0.003 DBMET03628 0.017 0.007 DBMET03629 0.017 0.006 DBMET03630 | DBMET03628 | |
| 0.02 | 0.008 | 0.081 | Glucocorticoid agonist | 0.02 0.008 DBMET00846 0.081 0.003 DBMET03627 0.059 0.004 DBMET01078 | DBMET03627 | |
| 0.091 | 0.09 | 0.102 | Chelator | 0.102 0.074 DBMET03627 0.095 0.085 DBMET01078 0.094 0.086 DBMET03628 | DBMET03627 | |
| 0.085 | 0.087 | 0.548 | Monophenol monooxygenase inhibitor | 0.206 0.032 DBMET03627 0.154 0.045 DBMET01078 0.118 0.063 DBMET00647 0.267 0.022 DBMET00847 0.28 0.02 DBMET03628 0.174 0.039 DBMET03629 0.548 0.006 DBMET03630 | DBMET03630 | |
| 0.103 | 0.109 | 0.284 | NADPH oxidase inhibitor | 0.231 0.025 DBMET03627 0.284 0.015 DBMET01078 | DBMET01078 | |
| 0.063 | 0.071 | 0.078 | Glycine receptor agonist | 0.078 0.042 DBMET00846 | DBMET00846 | |
| 0.055 | 0.062 | 0.112 | Phosphofructokinase-1 inhibitor | 0.065 0.052 DBMET00846 0.112 0.027 DBMET03630 | DBMET03630 | |
| 0.086 | 0.098 | 0.153 | Toll-Like receptor 4 antagonist | 0.092 0.084 DBMET00847 0.153 0.019 DBMET03630 | DBMET03630 | |
| 0.019 | 0.037 | 0.094 | Glucocorticoid antagonist | 0.094 0.005 DBMET03627 0.063 0.01 DBMET01078 0.03 0.024 DBMET00847 | DBMET03627 | |
| 0.042 | 0.062 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 DBMET01078 0.067 0.018 DBMET03630 | DBMET03630 | |
| 0.103 | 0.129 | 0.169 | Neurotrophic factor | 0.169 0.045 DBMET01078 0.119 0.096 DBMET00847 0.119 0.096 DBMET03628 0.114 0.106 DBMET03630 | DBMET01078 | |
| 0.103 | 0.13 | 0.334 | Cell wall synthesis inhibitor | 0.178 0.041 DBMET03628 0.288 0.011 DBMET03629 0.334 0.008 DBMET03630 | DBMET03630 | |
| 0.05 | 0.083 | 0.084 | Neuraminidase (influenza) inhibitor | 0.06 0.053 DBMET00647 0.083 0.023 DBMET03629 0.084 0.023 DBMET03630 | DBMET03630 | |
| 0.119 | 0.153 | 0.223 | Interleukin antagonist | 0.223 0.072 DBMET03627 0.18 0.096 DBMET01078 0.155 0.114 DBMET00847 0.17 0.104 DBMET03628 | DBMET03627 | |
| 0.075 | 0.113 | 0.133 | Estrogen receptor beta antagonist | 0.133 0.022 DBMET03627 0.12 0.031 DBMET01078 0.114 0.04 DBMET00847 0.13 0.023 DBMET03628 0.109 0.048 DBMET03629 | DBMET03627 | |
| 0.036 | 0.082 | 0.081 | Neuraminidase inhibitor | 0.054 0.052 DBMET00647 0.07 0.034 DBMET03629 0.081 0.025 DBMET03630 | DBMET03630 | |
| 0.119 | 0.165 | 0.206 | Antimitotic | 0.186 0.093 DBMET03627 0.206 0.08 DBMET01078 | DBMET01078 | |
| 0.011 | 0.058 | 0.025 | RNA-directed RNA polymerase stimulant | 0.025 0.024 DBMET03628 | DBMET03628 | |
| 0.029 | 0.078 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.048 0.028 DBMET03630 | DBMET03630 | |
| 0.153 | 0.202 | 0.178 | Nitric-oxide synthase stimulant | 0.166 0.163 DBMET00846 0.168 0.159 DBMET00647 0.178 0.132 DBMET03628 0.171 0.151 DBMET03630 | DBMET03628 | |
| 0.019 | 0.069 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET03629 0.03 0.011 DBMET03630 | DBMET03630 | |
| 0.103 | 0.153 | 0.247 | Arachidonic acid antagonist | 0.247 0.006 DBMET03627 0.232 0.011 DBMET01078 0.207 0.026 DBMET00847 0.218 0.019 DBMET03628 0.174 0.061 DBMET03629 0.149 0.09 DBMET03630 | DBMET03627 | |
| 0.07 | 0.141 | 0.106 | Glutamate release inhibitor | 0.097 0.048 DBMET03627 0.106 0.034 DBMET00847 0.088 0.067 DBMET03628 0.095 0.051 DBMET03630 | DBMET00847 | |
| 0.031 | 0.104 | 0.09 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET03628 0.07 0.017 DBMET03629 0.09 0.008 DBMET03630 | DBMET03630 | |
| 0.098 | 0.177 | 0.183 | Heat shock protein 90 alpha antagonist | 0.17 0.069 DBMET03627 0.183 0.06 DBMET01078 | DBMET01078 | |
| 0.075 | 0.16 | 0.141 | Electron transport complex I inhibitor | 0.106 0.069 DBMET03627 0.097 0.089 DBMET01078 0.099 0.085 DBMET00647 0.141 0.026 DBMET00847 0.125 0.041 DBMET03628 | DBMET00847 | |
| 0.046 | 0.131 | 0.2 | CDC25A inhibitor | 0.089 0.035 DBMET03627 0.076 0.048 DBMET01078 0.086 0.037 DBMET00847 0.106 0.024 DBMET03628 0.2 0.007 DBMET03629 | DBMET03629 | |
| 0.013 | 0.109 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET03629 0.028 0.019 DBMET03630 | DBMET03629 | |
| 0.019 | 0.118 | 0.087 | Aldose reductase inhibitor | 0.045 0.044 DBMET03627 0.049 0.04 DBMET00847 0.066 0.029 DBMET03628 0.067 0.029 DBMET03629 0.087 0.021 DBMET03630 | DBMET03630 | |
| 0.094 | 0.193 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.067 DBMET03627 0.119 0.083 DBMET01078 0.116 0.092 DBMET00847 0.117 0.09 DBMET03628 | DBMET03627 | |
| 0.039 | 0.14 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.022 DBMET03629 0.053 0.048 DBMET03630 | DBMET03629 | |
| 0.005 | 0.109 | 0.014 | Prostacyclin agonist | 0.014 0.013 DBMET00847 0.014 0.013 DBMET03628 | DBMET03628 | |
| 0.06 | 0.164 | 0.138 | DNA polymerase I inhibitor | 0.122 0.066 DBMET03628 0.138 0.056 DBMET03630 | DBMET03630 | |
| 0.009 | 0.118 | 0.026 | Dopamine D1 agonist | 0.026 0.012 DBMET03629 0.022 0.016 DBMET03630 | DBMET03629 | |
| 0.019 | 0.129 | 0.089 | Mannosidase inhibitor | 0.042 0.037 DBMET03628 0.061 0.016 DBMET03629 0.089 0.007 DBMET03630 | DBMET03630 | |
| 0.086 | 0.197 | 0.154 | Heat shock protein 90 antagonist | 0.145 0.079 DBMET03627 0.154 0.07 DBMET01078 | DBMET01078 | |
| 0.033 | 0.146 | 0.099 | CDC25B inhibitor | 0.088 0.022 DBMET03627 0.065 0.043 DBMET01078 0.08 0.028 DBMET00847 0.099 0.016 DBMET03628 | DBMET03628 | |
| 0.053 | 0.167 | 0.166 | UDP-glucose 4-epimerase inhibitor | 0.089 0.075 DBMET03628 0.166 0.024 DBMET03630 | DBMET03630 | |
| 0.011 | 0.128 | 0.254 | Estrogen agonist | 0.05 0.035 DBMET03627 0.05 0.035 DBMET00847 0.079 0.023 DBMET03628 0.254 0.006 DBMET03629 0.075 0.025 DBMET03630 | DBMET03629 | |
| 0.005 | 0.127 | 0.11 | Estrone sulfatase inhibitor | 0.026 0.012 DBMET03627 0.019 0.018 DBMET00847 0.024 0.013 DBMET03628 0.11 0.004 DBMET03629 | DBMET03629 | |
| 0.102 | 0.231 | 0.263 | Tumour necrosis factor alpha release inhibitor | 0.263 0.069 DBMET03630 | DBMET03630 | |
| 0.119 | 0.25 | 0.276 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.276 0.032 DBMET03627 0.253 0.041 DBMET01078 0.222 0.057 DBMET00847 0.225 0.055 DBMET03628 | DBMET03627 | |
| 0.045 | 0.179 | 0.088 | Antineoplastic alkaloid | 0.088 0.056 DBMET03627 0.088 0.057 DBMET01078 0.082 0.063 DBMET00847 | DBMET01078 | |
| 0.053 | 0.188 | 0.192 | Tubulin antagonist | 0.192 0.039 DBMET03627 0.155 0.055 DBMET01078 0.133 0.069 DBMET00847 | DBMET03627 | |
| 0.004 | 0.14 | 0.045 | Estrogen receptor alpha agonist | 0.045 0.019 DBMET03628 0.039 0.021 DBMET03629 | DBMET03628 | |
| 0.127 | 0.265 | 0.56 | Cholesterol antagonist | 0.278 0.106 DBMET03627 0.203 0.162 DBMET01078 0.31 0.085 DBMET00847 0.309 0.085 DBMET03628 0.494 0.034 DBMET03629 0.56 0.024 DBMET03630 | DBMET03630 | |
| 0.009 | 0.149 | 0.039 | Prostaglandin D2 agonist | 0.039 0.013 DBMET00847 0.038 0.014 DBMET03628 | DBMET00847 | |
| 0.005 | 0.145 | 0.134 | Estrogen receptor beta agonist | 0.035 0.022 DBMET03628 0.134 0.008 DBMET03629 | DBMET03629 | |
| 0.142 | 0.285 | 0.346 | Sodium/bile acid cotransporter inhibitor | 0.334 0.051 DBMET03627 0.311 0.07 DBMET01078 0.346 0.042 DBMET00847 0.339 0.047 DBMET03628 0.333 0.052 DBMET03629 0.265 0.113 DBMET03630 | DBMET00847 | |
| 0.047 | 0.201 | 0.308 | Cholesterol synthesis inhibitor | 0.132 0.055 DBMET03627 0.105 0.08 DBMET01078 0.218 0.023 DBMET00847 0.247 0.018 DBMET03628 0.308 0.01 DBMET03629 0.148 0.046 DBMET03630 | DBMET03629 | |
| 0.015 | 0.171 | 0.05 | Alpha tubulin antagonist | 0.05 0.04 DBMET03627 0.047 0.045 DBMET00847 | DBMET03627 | |
| 0.063 | 0.225 | 0.118 | Interleukin 1 antagonist | 0.118 0.092 DBMET03627 | DBMET03627 | |
| 0.049 | 0.215 | 0.18 | Xanthine oxidase inhibitor | 0.087 0.078 DBMET03627 0.084 0.083 DBMET01078 0.096 0.064 DBMET00847 0.109 0.054 DBMET03628 0.18 0.024 DBMET03630 | DBMET03630 | |
| 0.072 | 0.246 | 0.195 | Anesthetic general | 0.195 0.077 DBMET03627 | DBMET03627 | |
| 0.01 | 0.184 | 0.079 | Beta tubulin antagonist | 0.079 0.03 DBMET03627 0.055 0.043 DBMET01078 0.057 0.042 DBMET00847 | DBMET03627 | |
| 0.051 | 0.233 | 0.21 | Thrombolytic | 0.21 0.047 DBMET03630 | DBMET03630 | |
| 0.074 | 0.264 | 0.353 | Interleukin agonist | 0.178 0.141 DBMET03627 0.246 0.082 DBMET00847 0.242 0.085 DBMET03628 0.353 0.028 DBMET03630 | DBMET03630 | |
| 0.006 | 0.198 | 0.099 | Sodium/glucose cotransporter 2 inhibitor | 0.024 0.022 DBMET00847 0.026 0.02 DBMET03628 0.099 0.003 DBMET03630 | DBMET03630 | |
| 0.024 | 0.217 | 0.068 | Factor IXa inhibitor | 0.068 0.021 DBMET03629 0.059 0.028 DBMET03630 | DBMET03629 | |
| 0.014 | 0.211 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.029 DBMET03628 | DBMET03628 | |
| 0.054 | 0.258 | 0.185 | Photosensitizer | 0.138 0.04 DBMET03627 0.119 0.058 DBMET01078 0.147 0.033 DBMET00847 0.148 0.032 DBMET03628 0.185 0.016 DBMET03630 | DBMET03630 | |
| 0.025 | 0.23 | 0.211 | Androgen antagonist | 0.211 0.013 DBMET03627 0.159 0.02 DBMET01078 0.083 0.062 DBMET00847 0.112 0.038 DBMET03628 | DBMET03627 | |
| 0.037 | 0.245 | 0.06 | Heme oxygenase stimulant | 0.058 0.052 DBMET03627 0.06 0.045 DBMET03628 | DBMET03628 | |
| 0.149 | 0.363 | 0.701 | Cyclophilin D inhibitor | 0.301 0.162 DBMET03628 0.317 0.148 DBMET03629 0.701 0.014 DBMET03630 | DBMET03630 | |
| 0.054 | 0.273 | 0.158 | Cell adhesion inhibitor | 0.158 0.042 DBMET03630 | DBMET03630 | |
| 0.067 | 0.292 | 0.243 | Sigma receptor agonist | 0.243 0.05 DBMET03627 0.152 0.084 DBMET01078 0.201 0.061 DBMET00847 | DBMET03627 | |
| 0.041 | 0.273 | 0.09 | Thioredoxin inhibitor | 0.09 0.063 DBMET03630 | DBMET03630 | |
| 0.07 | 0.309 | 0.15 | Adenylate cyclase stimulant | 0.132 0.097 DBMET00847 0.149 0.065 DBMET03628 0.15 0.063 DBMET03629 | DBMET03629 | |
| 0.073 | 0.316 | 0.192 | Streptokinase A inhibitor | 0.192 0.138 DBMET03627 | DBMET03627 | |
| 0.023 | 0.291 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.085 0.054 DBMET03627 0.082 0.058 DBMET01078 | DBMET03627 | |
| 0.006 | 0.277 | 0.076 | Sodium/glucose cotransporter inhibitor | 0.076 0.004 DBMET03630 | DBMET03630 | |
| 0.073 | 0.345 | 0.229 | Neurotrophic factor enhancer | 0.191 0.086 DBMET03627 0.176 0.103 DBMET00847 0.229 0.052 DBMET03628 0.217 0.061 DBMET03630 | DBMET03628 | |
| 0.008 | 0.28 | 0.035 | ATP citrate lysase inhibitor | 0.035 0.017 DBMET03628 | DBMET03628 | |
| 0.024 | 0.304 | 0.049 | Factor III inhibitor | 0.049 0.037 DBMET03630 | DBMET03630 | |
| 0.056 | 0.337 | 0.226 | Hexokinase inhibitor | 0.141 0.09 DBMET03627 0.142 0.088 DBMET03628 0.226 0.023 DBMET03630 | DBMET03630 | |
| 0.038 | 0.321 | 0.147 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.083 DBMET03628 0.147 0.057 DBMET03630 | DBMET03630 | |
| 0.017 | 0.3 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.043 0.042 DBMET03628 0.053 0.026 DBMET03630 | DBMET03630 | |
| 0.019 | 0.305 | 0.178 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.178 0.012 DBMET03627 0.135 0.024 DBMET01078 0.132 0.025 DBMET00847 0.136 0.023 DBMET03628 | DBMET03627 | |
| 0.022 | 0.31 | 0.182 | 5-Lipoxygenase inhibitor | 0.144 0.04 DBMET03627 0.103 0.062 DBMET01078 0.146 0.039 DBMET00847 0.182 0.028 DBMET03628 | DBMET03628 | |
| 0.035 | 0.323 | 0.309 | Protein-tyrosine phosphatase inhibitor | 0.12 0.114 DBMET03628 0.309 0.017 DBMET03629 0.125 0.107 DBMET03630 | DBMET03629 | |
| 0.033 | 0.325 | 0.23 | Beta glucuronidase inhibitor | 0.095 0.078 DBMET03627 0.092 0.084 DBMET01078 0.101 0.068 DBMET00847 0.104 0.063 DBMET03628 0.23 0.01 DBMET03630 | DBMET03630 | |
| 0.039 | 0.332 | 0.129 | Adenylate cyclase inhibitor | 0.129 0.06 DBMET03628 | DBMET03628 | |
| 0.079 | 0.377 | 0.174 | Transcription factor STAT3 inhibitor | 0.174 0.173 DBMET01078 | DBMET01078 | |
| 0.031 | 0.334 | 0.316 | AMP-activated protein kinase stimulant | 0.104 0.065 DBMET00847 0.149 0.029 DBMET03628 0.316 0.005 DBMET03630 | DBMET03630 | |
| 0.012 | 0.331 | 0.079 | Leukotriene B4 antagonist | 0.053 0.038 DBMET03627 0.06 0.027 DBMET00847 0.065 0.023 DBMET03628 0.065 0.023 DBMET03629 0.079 0.016 DBMET03630 | DBMET03630 | |
| 0.035 | 0.355 | 0.098 | NADH dehydrogenase inhibitor | 0.098 0.046 DBMET03630 | DBMET03630 | |
| 0.089 | 0.413 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.063 DBMET03630 | DBMET03630 | |
| 0.011 | 0.339 | 0.048 | Maillard reaction inhibitor | 0.048 0.046 DBMET03628 | DBMET03628 | |
| 0.128 | 0.456 | 0.456 | 5 Hydroxytryptamine release inhibitor | 0.327 0.137 DBMET03627 0.272 0.198 DBMET01078 0.401 0.078 DBMET00847 0.366 0.102 DBMET03628 0.456 0.049 DBMET03630 | DBMET03630 | |
| 0.026 | 0.365 | 0.116 | Sphingomyelinase inhibitor | 0.087 0.077 DBMET03627 0.11 0.049 DBMET00847 0.116 0.044 DBMET03628 | DBMET03628 | |
| 0.047 | 0.391 | 0.335 | Platelet adhesion inhibitor | 0.244 0.051 DBMET03629 0.335 0.024 DBMET03630 | DBMET03630 | |
| 0.052 | 0.397 | 0.17 | Insulin secretagoues | 0.17 0.055 DBMET03630 | DBMET03630 | |
| 0.127 | 0.476 | 0.45 | Calcium channel L-type activator | 0.266 0.188 DBMET03627 0.24 0.217 DBMET00647 0.446 0.053 DBMET00847 0.45 0.05 DBMET03628 0.292 0.164 DBMET03629 0.279 0.175 DBMET03630 | DBMET03628 | |
| 0.013 | 0.363 | 0.168 | Protein-tyrosine phosphatase 1B inhibitor | 0.168 0.039 DBMET03629 0.093 0.086 DBMET03630 | DBMET03629 | |
| 0.006 | 0.363 | 0.108 | Aromatase inhibitor | 0.108 0.02 DBMET03627 0.08 0.028 DBMET01078 | DBMET03627 | |
| 0.034 | 0.392 | 0.128 | Antibacterial (Helicobacter pylori) | 0.113 0.092 DBMET03627 0.121 0.08 DBMET01078 0.126 0.073 DBMET00847 0.128 0.07 DBMET03628 | DBMET03628 | |
| 0.017 | 0.389 | 0.108 | Carbonic anhydrase XIII inhibitor | 0.108 0.034 DBMET03629 | DBMET03629 | |
| 0.004 | 0.387 | 0.058 | Dopamine D2 agonist | 0.058 0.022 DBMET03629 | DBMET03629 | |
| 0.017 | 0.4 | 0.072 | Glycine receptor antagonist | 0.072 0.071 DBMET03629 | DBMET03629 | |
| 0.011 | 0.406 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET03629 | DBMET03629 | |
| 0.027 | 0.437 | 0.231 | Triose-phosphate isomerase inhibitor | 0.098 0.05 DBMET03628 0.231 0.008 DBMET03629 0.142 0.022 DBMET03630 | DBMET03629 | |
| 0.035 | 0.449 | 0.239 | Platelet antagonist | 0.239 0.078 DBMET03630 | DBMET03630 | |
| 0.052 | 0.474 | 0.114 | Vanilloid 1 agonist | 0.114 0.104 DBMET03627 | DBMET03627 | |
| 0.029 | 0.452 | 0.11 | Toll-Like receptor 2 antagonist | 0.11 0.089 DBMET03627 | DBMET03627 | |
| 0.043 | 0.512 | 0.15 | Phospholipase C inhibitor | 0.15 0.106 DBMET03629 | DBMET03629 | |
| 0.02 | 0.491 | 0.162 | Anabolic | 0.099 0.064 DBMET03627 0.116 0.044 DBMET00847 0.15 0.018 DBMET03628 0.162 0.012 DBMET03629 | DBMET03629 | |
| 0.02 | 0.492 | 0.117 | Keratolytic | 0.117 0.023 DBMET03627 0.086 0.041 DBMET01078 0.112 0.024 DBMET00847 0.111 0.025 DBMET03628 | DBMET03627 | |
| 0.026 | 0.503 | 0.219 | Hypolipemic | 0.219 0.083 DBMET03630 | DBMET03630 | |
| 0.025 | 0.504 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.057 DBMET03628 | DBMET03628 | |
| 0.026 | 0.511 | 0.16 | Aldehyde dehydrogenase inhibitor | 0.16 0.042 DBMET03627 0.113 0.079 DBMET01078 0.123 0.068 DBMET03628 0.105 0.09 DBMET03630 | DBMET03627 | |
| 0.054 | 0.541 | 0.395 | Histamine release inhibitor | 0.224 0.177 DBMET03627 0.236 0.166 DBMET00847 0.279 0.136 DBMET03628 0.395 0.078 DBMET03630 | DBMET03630 | |
| 0.03 | 0.528 | 0.698 | Aldehyde oxidase inhibitor | 0.675 0.01 DBMET03627 0.447 0.04 DBMET01078 0.646 0.013 DBMET00847 0.698 0.008 DBMET03628 0.165 0.126 DBMET03629 | DBMET03628 | |
| 0.025 | 0.53 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | 0.096 0.041 DBMET03627 | DBMET03627 | |
| 0.051 | 0.558 | 0.325 | Toll-Like receptor agonist | 0.325 0.096 DBMET00847 0.31 0.104 DBMET03628 0.261 0.138 DBMET03630 | DBMET00847 | |
| 0.065 | 0.577 | 0.467 | Calcium channel activator | 0.415 0.02 DBMET03627 0.352 0.048 DBMET01078 0.467 0.008 DBMET00847 0.39 0.028 DBMET03628 0.259 0.136 DBMET03629 | DBMET00847 | |
| 0.051 | 0.564 | 0.314 | Toll-Like receptor 7 agonist | 0.314 0.101 DBMET00847 0.297 0.112 DBMET03628 0.237 0.16 DBMET03630 | DBMET00847 | |
| 0.034 | 0.564 | 0.415 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET03627 0.309 0.038 DBMET00847 0.29 0.046 DBMET03628 0.415 0.014 DBMET03630 | DBMET03630 | |
| 0.005 | 0.535 | 0.054 | Alcohol oxidase inhibitor | 0.054 0.041 DBMET03628 | DBMET03628 | |
| 0.023 | 0.553 | 0.115 | Acetylcholine release stimulant | 0.115 0.057 DBMET03627 0.112 0.062 DBMET03629 | DBMET03627 | |
| 0.013 | 0.558 | 0.104 | Mediator release inhibitor | 0.104 0.066 DBMET03630 | DBMET03630 | |
| 0.047 | 0.596 | 0.336 | Vasodilator, coronary | 0.206 0.176 DBMET00847 0.336 0.063 DBMET03630 | DBMET03630 | |
| 0.021 | 0.575 | 0.097 | Carbonic anhydrase III inhibitor | 0.097 0.065 DBMET03628 | DBMET03628 | |
| 0.019 | 0.59 | 0.353 | Dual specificity phosphatase inhibitor | 0.135 0.112 DBMET03627 0.127 0.125 DBMET00847 0.142 0.104 DBMET03628 0.353 0.02 DBMET03629 | DBMET03629 | |
| 0.018 | 0.594 | 0.316 | Spasmolytic | 0.191 0.128 DBMET03627 0.21 0.111 DBMET00847 0.225 0.103 DBMET03628 0.316 0.064 DBMET03630 | DBMET03630 | |
| 0.011 | 0.589 | 0.135 | Mcl-1 antagonist | 0.135 0.106 DBMET03627 | DBMET03627 | |
| 0.004 | 0.585 | 0.058 | Leukotriene antagonist | 0.058 0.053 DBMET03628 | DBMET03628 | |
| 0.014 | 0.615 | 0.127 | Estrogen receptor alpha antagonist | 0.102 0.026 DBMET03627 0.078 0.052 DBMET01078 0.098 0.029 DBMET00847 0.127 0.016 DBMET03628 | DBMET03628 | |
| 0.003 | 0.608 | 0.067 | Potassium channel Kv1.3 blocker | 0.063 0.019 DBMET03627 0.067 0.017 DBMET00847 | DBMET00847 | |
| 0.009 | 0.625 | 0.051 | Vanilloid 3 antagonist | 0.051 0.008 DBMET03627 0.037 0.029 DBMET01078 0.046 0.013 DBMET00847 0.036 0.034 DBMET03628 | DBMET03627 | |
| 0.017 | 0.634 | 0.293 | Lipoxygenase inhibitor | 0.27 0.087 DBMET03627 0.198 0.142 DBMET01078 0.289 0.077 DBMET00847 0.293 0.075 DBMET03628 | DBMET03628 | |
| 0.017 | 0.643 | 0.134 | DOPA decarboxylase inhibitor | 0.123 0.042 DBMET03627 0.097 0.083 DBMET00847 0.134 0.032 DBMET03628 | DBMET03628 | |
| 0.018 | 0.654 | 0.182 | Succinate dehydrogenase inhibitor | 0.182 0.065 DBMET03627 0.142 0.127 DBMET01078 0.149 0.114 DBMET00847 0.152 0.108 DBMET03628 | DBMET03627 | |
| 0.013 | 0.655 | 0.226 | Insulin sensitizer | 0.207 0.066 DBMET00847 0.226 0.05 DBMET03628 0.173 0.103 DBMET03630 | DBMET03628 | |
| 0.002 | 0.648 | 0.041 | Progesterone antagonist | 0.041 0.022 DBMET03627 | DBMET03627 | |
| 0.037 | 0.686 | 0.258 | Vasodilator, peripheral | 0.258 0.121 DBMET00847 0.213 0.162 DBMET03628 | DBMET00847 | |
| 0.067 | 0.732 | 0.205 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.142 DBMET03627 | DBMET03627 | |
| 0.005 | 0.684 | 0.284 | Diuretic | 0.284 0.025 DBMET03629 0.148 0.079 DBMET03630 | DBMET03629 | |
| 0.009 | 0.692 | 0.048 | Aldosterone antagonist | 0.048 0.032 DBMET03627 | DBMET03627 | |
| 0.019 | 0.702 | 0.456 | Peroxidase inhibitor | 0.113 0.107 DBMET03627 0.309 0.036 DBMET00847 0.456 0.014 DBMET03628 0.16 0.073 DBMET03629 | DBMET03628 | |
| 0.004 | 0.692 | 0.074 | Glutamate decarboxylase inhibitor | 0.074 0.05 DBMET03628 | DBMET03628 | |
| 0.007 | 0.696 | 0.056 | Pregnane X receptor antagonist | 0.053 0.05 DBMET03627 0.056 0.04 DBMET00847 | DBMET00847 | |
| 0.008 | 0.697 | 0.053 | Fatty acid synthase inhibitor | 0.053 0.045 DBMET03628 | DBMET03628 | |
| 0.005 | 0.7 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 DBMET03628 | DBMET03628 | |
| 0.009 | 0.708 | 0.294 | Anticoagulant | 0.294 0.029 DBMET03629 | DBMET03629 | |
| 0.009 | 0.708 | 0.165 | Creatine kinase inhibitor | 0.09 0.072 DBMET03627 0.165 0.018 DBMET03628 | DBMET03628 | |
| 0.048 | 0.748 | 0.229 | Tyrosine 3 hydroxylase inhibitor | 0.229 0.091 DBMET03627 0.197 0.14 DBMET03628 | DBMET03627 | |
| 0.006 | 0.717 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.03 DBMET03628 | DBMET03628 | |
| 0.004 | 0.715 | 0.072 | Catalase inhibitor | 0.072 0.053 DBMET03629 | DBMET03629 | |
| 0.004 | 0.716 | 0.082 | MAO A inhibitor | 0.082 0.079 DBMET03628 | DBMET03628 | |
| 0.004 | 0.722 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.045 DBMET00847 | DBMET00847 | |
| 0.014 | 0.743 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.072 DBMET00847 0.139 0.03 DBMET03628 | DBMET03628 | |
| 0.006 | 0.74 | 0.087 | Bronchodilator | 0.087 0.078 DBMET00847 | DBMET00847 | |
| 0.002 | 0.736 | 0.055 | Estradiol 17 beta-dehydrogenase inhibitor | 0.037 0.033 DBMET03627 0.038 0.033 DBMET00847 0.055 0.022 DBMET03628 | DBMET03628 | |
| 0.02 | 0.76 | 0.163 | Tumour necrosis factor antagonist | 0.163 0.084 DBMET03627 | DBMET03627 | |
| 0.011 | 0.777 | 0.217 | Antipruritic | 0.217 0.038 DBMET03627 | DBMET03627 | |
| 0.008 | 0.781 | 0.212 | Dual specificity phosphatase 3 inhibitor | 0.212 0.055 DBMET03629 | DBMET03629 | |
| 0.014 | 0.801 | 0.119 | Nav1.4 sodium channel blocker | 0.119 0.053 DBMET03629 | DBMET03629 | |
| 0.005 | 0.799 | 0.052 | Elastase inhibitor | 0.052 0.039 DBMET03629 | DBMET03629 | |
| 0.008 | 0.803 | 0.224 | Non-steroidal antiinflammatory agent | 0.224 0.055 DBMET03630 | DBMET03630 | |
| 0.006 | 0.804 | 0.092 | Cathepsin G inhibitor | 0.092 0.036 DBMET03629 | DBMET03629 | |
| 0.01 | 0.823 | 0.275 | Hemostatic | 0.275 0.019 DBMET03629 0.2 0.032 DBMET03630 | DBMET03629 | |
| 0.004 | 0.835 | 0.172 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.172 0.119 DBMET03627 | DBMET03627 | |
| 0.004 | 0.84 | 0.06 | Beta 3 adrenoreceptor antagonist | 0.06 0.056 DBMET00847 | DBMET00847 | |
| 0.007 | 0.856 | 0.474 | Cholecystokinin B agonist | 0.474 0.002 DBMET03629 | DBMET03629 | |
| 0.003 | 0.869 | 0.035 | NMDA 2D receptor antagonist | 0.035 0.012 DBMET03629 | DBMET03629 | |
| 0.014 | 0.903 | 0.21 | GABA C receptor rho-3 antagonist | 0.21 0.196 DBMET03628 | DBMET03628 | |
| 0.002 | 0.902 | 0.121 | NMDA receptor antagonist | 0.096 0.05 DBMET03628 0.121 0.035 DBMET03629 | DBMET03629 | |
| 0.002 | 0.909 | 0.205 | Cholecystokinin A agonist | 0.205 0.003 DBMET03629 | DBMET03629 | |
| 0.003 | 0.918 | 0.206 | NMDA 2B receptor antagonist | 0.206 0.005 DBMET03629 | DBMET03629 | |
| 0.002 | 0.917 | 0.251 | Cholecystokinin agonist | 0.251 0.003 DBMET03629 | DBMET03629 | |
| 0.002 | 0.935 | 0.05 | Cholecystokinin B antagonist | 0.05 0.01 DBMET03629 | DBMET03629 | |
| 0.002 | 0.949 | 0.066 | Cholecystokinin antagonist | 0.066 0.015 DBMET03629 | DBMET03629 | |
| 0.001 | 0.958 | 0.078 | NMDA 2 receptor antagonist | 0.078 0.045 DBMET03629 | DBMET03629 | |
| 0.002 | 0.975 | 0.099 | Cholecystokinin A antagonist | 0.099 0.009 DBMET03629 | DBMET03629 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |